AstraZeneca PLC (AZN)
71.43
+0.01
(+0.01%)
USD |
NASDAQ |
Nov 04, 16:00
71.43
0.00 (0.00%)
After-Hours: 20:00
AstraZeneca Price to Book Value: 5.605 for Nov. 4, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 5.604 |
| October 31, 2024 | 5.583 |
| October 30, 2024 | 5.715 |
| October 29, 2024 | 5.903 |
| October 28, 2024 | 5.965 |
| October 25, 2024 | 5.889 |
| October 24, 2024 | 5.956 |
| October 23, 2024 | 6.038 |
| October 22, 2024 | 6.067 |
| October 21, 2024 | 6.077 |
| October 18, 2024 | 6.141 |
| October 17, 2024 | 6.122 |
| October 16, 2024 | 6.145 |
| October 15, 2024 | 6.109 |
| October 14, 2024 | 6.129 |
| October 11, 2024 | 6.070 |
| October 10, 2024 | 6.032 |
| October 09, 2024 | 6.082 |
| October 08, 2024 | 6.032 |
| October 07, 2024 | 6.032 |
| October 04, 2024 | 6.079 |
| October 03, 2024 | 6.115 |
| October 02, 2024 | 6.245 |
| October 01, 2024 | 6.173 |
| September 30, 2024 | 6.114 |
| Date | Value |
|---|---|
| September 27, 2024 | 6.091 |
| September 26, 2024 | 6.135 |
| September 25, 2024 | 6.085 |
| September 24, 2024 | 6.032 |
| September 23, 2024 | 6.053 |
| September 20, 2024 | 6.150 |
| September 19, 2024 | 6.191 |
| September 18, 2024 | 6.166 |
| September 17, 2024 | 6.162 |
| September 16, 2024 | 6.202 |
| September 13, 2024 | 6.142 |
| September 12, 2024 | 6.196 |
| September 11, 2024 | 6.319 |
| September 10, 2024 | 6.369 |
| September 09, 2024 | 6.348 |
| September 06, 2024 | 6.517 |
| September 05, 2024 | 6.513 |
| September 04, 2024 | 6.729 |
| September 03, 2024 | 6.726 |
| August 30, 2024 | 6.876 |
| August 29, 2024 | 6.850 |
| August 28, 2024 | 6.855 |
| August 27, 2024 | 6.843 |
| August 26, 2024 | 6.797 |
| August 23, 2024 | 6.800 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
4.211
Minimum
Dec 10 2021
13.47
Maximum
May 13 2020
7.524
Average
6.150
Median
Price to Book Value Benchmarks
| Amgen Inc | 22.63 |
| GSK PLC | 4.025 |
| Johnson & Johnson | 5.430 |
| Sanofi SA | 1.703 |
| TC BioPharm (Holdings) PLC | 0.5075 |
Price to Book Value Related Metrics
| PE Ratio | 34.51 |
| PS Ratio | 4.542 |
| PEG Ratio | 7.592 |
| Price to Free Cash Flow | 32.03 |
| Price | 71.43 |
| Earnings Yield | 2.90% |
| Market Cap | 221.47B |
| PEGY Ratio | 5.209 |
| Operating PE Ratio | 22.73 |
| Normalized PE Ratio | 31.63 |